World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
43
Citations
6393
World Ranking
4854
National Ranking
2174

Overview

Richard B. Bankert is affiliated with the University at Buffalo, State University of New York in the United States. Their research primarily spans the fields of Immunology and Microbiology, Biochemistry, Genetics and Molecular Biology, and Medicine, with a notable focus on Immunology in particular.

Their work extensively addresses topics related to extracellular vesicles in disease, immunotherapy and immune responses, as well as phagocytosis and immune regulation. Other areas of research include microRNA in disease regulation, immune cell function and interaction, galectins and cancer biology, and SARS-CoV-2 and COVID-19 research.

Richard B. Bankert has contributed to several peer-reviewed publications, including:

  • Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments, 2021, Journal for ImmunoTherapy of Cancer
  • Tumor-Associated Exosomes: A Potential Therapeutic Target for Restoring Anti-Tumor T Cell Responses in Human Tumor Microenvironments, 2021, Cells
  • Exosomes Represent an Immune Suppressive T Cell Checkpoint in Human Chronic Inflammatory Microenvironments, 2020, Immunological Investigations
  • Rational design of a nanoparticle platform for oral prophylactic immunotherapy to prevent immunogenicity of therapeutic proteins, 2021, Scientific Reports
  • Preclinical evaluation of cancer immune therapy using patient-derived tumor antigen-specific T cells in a novel xenograft platform, 2021, Clinical & Translational Immunology

Their frequent coauthors include:

  • Gautam N. Shenoy
  • Maulasri Bhatta
  • Jenni Loyall
  • Raymond J. Kelleher
  • Sathy V. Balu-Iyer

Richard B. Bankert's publications have appeared in several scientific journals such as the Journal for ImmunoTherapy of Cancer, Cells, Immunological Investigations, Scientific Reports, and Clinical & Translational Immunology.

Best Publications

  • Integrin alpha 2 beta 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils.

    C E Klein;D Dressel;T Steinmayer;C Mauch

  • Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells.

    Michael R. Nazareth;Lori Broderick;Michelle R. Simpson-Abelson;Raymond J. Kelleher

  • Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a “vaccinal effect” of rituximab

    Shannon P. Hilchey;Ollivier Hyrien;Tim R. Mosmann;Alexandra M. Livingstone

  • In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity.

    Nejat K. Egilmez;Yong S. Jong;Michael S. Sabel;Jules S. Jacob

  • Cancer Immunotherapy with Interleukin 12 and Granulocyte-Macrophage Colony-stimulating Factor-encapsulated Microspheres: Coinduction of Innate and Adaptive Antitumor Immunity and Cure of Disseminated Disease

    Hank C. Hill;Thomas F. Conway;Michael S. Sabel;Yong S. Jong

  • Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes.

    Scott S. Williams;Thomas R. Alosco;Eric Mayhew;Danilo D. Lasic

  • Antibody Targeting of Doxorubicin-loaded Liposomes Suppresses the Growth and Metastatic Spread of Established Human Lung Tumor Xenografts in Severe Combined Immunodeficient Mice

    Masahiko Sugano;Nejat K. Egilmez;Sandra J. Yokota;Fang-An Chen

  • Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment.

    Kelly L. Singel;Tiffany R. Emmons;Anm Nazmul H. Khan;Paul C. Mayor

  • Long-Term Engraftment and Expansion of Tumor-Derived Memory T Cells Following the Implantation of Non-Disrupted Pieces of Human Lung Tumor into NOD-scid IL2Rγnull Mice

    Michelle R Simpson-Abelson;Gregory F Sonnenberg;Hiroshi Takita;Sandra J Yokota

  • Human Lung Tumor Growth Established in the Lung and Subcutaneous Tissue of Mice with Severe Combined Immunodeficiency

    S Reddy;D Piccione;H Takita;R B Bankert

  • Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies.

    Richard B Bankert;Nejat K Egilmez;Stephen D Hess

  • THE NEXT GENERATION OF LIPOSOME DELIVERY SYSTEMS: RECENT EXPERIENCE WITH TUMOR-TARGETED, STERICALLY-STABILIZED IMMUNOLIPOSOMES AND ACTIVE-LOADING GRADIENTS

    R. M. Abra;R. B. Bankert;F. Chen;N. K. Egilmez

  • Follicular Lymphoma Intratumoral CD4+CD25+GITR+ Regulatory T Cells Potently Suppress CD3/CD28-Costimulated Autologous and Allogeneic CD8+CD25− and CD4+CD25− T Cells

    Shannon P. Hilchey;Asit De;Lisa M. Rimsza;Richard B. Bankert

  • Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer.

    Nejat K. Egilmez;Yoshimi Iwanuma;Richard B. Bankert

  • Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine Dependent Arrest in the T Cell Signaling Cascade

    Raymond J Kelleher;Sathy Balu-Iyer;Jenni L Loyall;Anthony J Sacca

  • Sialic Acid-Dependent Inhibition of T Cells by Exosomal Ganglioside GD3 in Ovarian Tumor Microenvironments.

    Gautam N. Shenoy;Jenni Loyall;Charles S. Berenson;Charles S. Berenson;Raymond J. Kelleher

  • Immunogenicity of Subcutaneously Administered Therapeutic Proteins—a Mechanistic Perspective

    Anas M. Fathallah;Richard B. Bankert;Sathy V. Balu-Iyer

  • Human CD4+ T Cells Present Within the Microenvironment of Human Lung Tumors Are Mobilized by the Local and Sustained Release of IL-12 to Kill Tumors In Situ by Indirect Effects of IFN-γ

    Stephen D. Hess;Nejat K. Egilmez;Nicola Bailey;Timothy M. Anderson

  • Activation induces a rapid reorganization of spectrin in lymphocytes

    John K. Lee;John K. Lee;Jennifer D. Black;Elizabeth A. Repasky;Ralph T. Kubo

  • Human lung tumor-associated antigen identified as an extracellular matrix adhesion molecule.

    F A Chen;E A Repasky;R B Bankert

  • Human CD4+ Effector Memory T Cells Persisting in the Microenvironment of Lung Cancer Xenografts Are Activated by Local Delivery of IL-12 to Proliferate, Produce IFN-γ, and Eradicate Tumor Cells

    Lori Broderick;Sandra J. Yokota;Joshua Reineke;Edith Mathiowitz

Frequent Co-Authors

Elizabeth A. Repasky
Elizabeth A. Repasky Roswell Park Cancer Institute
Edith Mathiowitz
Edith Mathiowitz Brown University
Kunle Odunsi
Kunle Odunsi Roswell Park Cancer Institute
Leonard D. Shultz
Leonard D. Shultz Jackson Laboratory
Martin Morgan
Martin Morgan Roswell Park Cancer Institute
Paul K. Wallace
Paul K. Wallace Roswell Park Cancer Institute
Marc S. Ernstoff
Marc S. Ernstoff Roswell Park Cancer Institute
Nicholas J. Petrelli
Nicholas J. Petrelli Christiana Care Health System
Gerald P. Linette
Gerald P. Linette University of Pennsylvania
Ralph T. Kubo
Ralph T. Kubo Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many students begin with foundational nursing programs, such as easiest absn program to get into, which offer an accelerated path into nursing. These programs are ideal for non-nurses looking to transition quickly into clinical roles.

Alternatively, individuals without a nursing background can explore online bsn programs for non nurses, which provide flexible options to earn a Bachelor of Science in Nursing online. These degrees serve as a stepping stone toward advanced practice and specialized fields.

For those aiming to advance their clinical expertise, accelerated formats like the accelerated nurse practitioner program can be an effective route. These programs enable faster progression into nurse practitioner roles, which often engage with immunological conditions and treatments.

Furthermore, obtaining acute care np certification is another pathway for advanced practitioners focusing on critical care settings. This specialization enhances expertise in managing acute immunological disorders and complex patient needs.

Best Scientists Citing Richard B. Bankert

Trending Scientists

Recently Published Articles